JWH-019

from Wikipedia, the free encyclopedia
Structural formula
Structural formula of JWH-019
General
Surname JWH-019
other names
  • 1-hexyl-3- (1-naphthoyl) indole
  • Naphthalen-1-yl- (1-hexyl-1 H -indol-3-yl) methanone
Molecular formula C 25 H 25 NO
External identifiers / databases
CAS number 209414-08-4
PubChem 52224389
ChemSpider 24598813
Wikidata Q423592
Drug information
Drug class

Cannabinoid mimetic

Mechanism of action

Cannabinoid receptor CB 1 / CB 2 agonist

properties
Molar mass 355.47 g mol −1
safety instructions
GHS hazard labeling
no classification available
As far as possible and customary, SI units are used. Unless otherwise noted, the data given apply to standard conditions .

JWH-019 is a synthetic chemical compound from the group of alkyl indole - derivatives and was designed by John W. Huffman developed. The fabric is in the capacity as cannabinoid receptor - CB 1 / CB 2 - agonist cannabinoid mimetic effect.

This cannabinoid was found as an artificially added active ingredient in products that were marketed by the manufacturers as “herbal mixtures”, for example under the name “ Spice ”, or in similar products. According to the Expert Committee for Narcotics in Germany, JWH-019 has a stronger effect than tetrahydrocannabinol (THC), the main active ingredient of the hemp plant ( Cannabis sativa ).

Legal position

  • Germany
As an active ingredient , JWH-019 was classified as a marketable but not prescription narcotic drug in Germany through its entry in Annex II of the Narcotics Act (BtMG) .
  • Switzerland
With the entry into force of the revised Narcotics Ordinance by Swissmedic on December 1, 2010, JWH-019 will be subject to the Narcotics Act and will therefore be illegal from this point on. Importation, possession, distribution etc. are punished according to the Narcotics Act.

See also

Individual evidence

  1. ↑ This substance has either not yet been classified with regard to its hazardousness or a reliable and citable source has not yet been found.
  2. ↑ Federal Law Gazette 2009 I p. 3944
  3. ↑ Federal Institute for Drugs and Medical Devices (BfArM): Committee of Experts for Narcotics according to Section 1, Paragraph 2 of the BtMG. ( Memento of December 30, 2014 in the Internet Archive ) As of August 26, 2009, accessed on September 27, 2010
  4. ↑ Federal Institute for Drugs and Medical Devices (BfArM): Narcotics. As of June 1, 2010, accessed on September 27, 2010.
  5. ↑ Ordinance of the Swiss Agency for Therapeutic Products on Narcotic Drugs and Psychotropic Substances (Narcotics Ordinance Swissmedic, BetmV-Swissmedic.) Amendment of 10 September 2010 (PDF; 576 kB) Comes into force on 1 December 2010.
  6. ↑ Federal Act on Narcotics and Psychotropic Substances (Narcotics Act, BetmG) of October 3, 1951 (as of January 1, 2010) (PDF; 179 kB). Swiss Narcotics Act, relevant criminal provisions: Art. 19 and following.